Scientific Program
14 September 2022 (Wednesday), Day 1 |
||
|
10.00-18.00 |
Registration & Poster move in |
|
|
13.00-13.30 |
Opening Ceremony |
|
|
Plenary Session – Hall 1 |
||
|
Chairs: F. Altuntas, M. Lozano, C. Andersen, C. Fernandez |
||
|
13.30-14.00 |
Cohn de Laval Award and Lecture |
|
|
14.00-14.30 |
Helmut Borberg Award and Lecture |
|
|
14.30-15.30 |
Coffee Break & Poster Session 1 |
|
|
Scientific Session I |
||
|
Chairs: A. Ünal, A. Buser |
||
|
Hall 1 |
||
|
15.30-16.00 |
Apheresis in Long-Haul COVID D. Kiprov |
|
|
16.00-16.30 |
Is there a role of TPE in severe COVID-19 infection? |
|
|
16.30-17.00 |
Nurses perspective of apheresis in SARS-CoV-2 infected patients |
|
|
17.00-18.30 |
Welcome Reception – (open to all registrants) |
|
|
18.00-19.30 |
Pre-Congress board meeting for the WAA (by invitation only) |
|
|
20.00 |
Dinner (by invitation only) |
|
15 September 2022 (Thursday), Day 2 |
||
|
Scientific Session II |
Educational Session I |
|
|
Chairs: S. Korkmaz, N. Worel |
Chairs: C. Anderson, S. Çağırgan |
|
|
Hall 1 |
Hall 2 |
|
|
09.00-09.30 |
Apheresis collection of the correct cells for CAR-Ts |
Basics of apheresis and equipment |
|
09.30-10.00 |
CAR-T cell production in the academic center (regulations / quality / profit) |
Basic Physiology of Therapeutic Plazma Exchange |
|
10.00-10.30 |
FACT/JACIE Standards for Cellular Therapy Collection facilities (CAR T-cells) |
Apheresis Mathematics |
|
10.30-11.00 |
Coffee Break |
|
|
Scientific Session III |
Educational Session II |
|
|
Chairs: F. Altuntas, G. Leitner |
Chairs: L. Ündar, M. Yağcı |
|
|
Hall 1 |
Hall 2 |
|
|
11.00-11.30 |
Clinical use of CAR-T cells in treating ALL |
Qualification in Apheresis (QIA): a New Credential for Apheresis Professionals |
|
11.30-12.00 |
Clinical use of CAR-T-cells in Multiple Myeloma |
Therapeutic Apheresis Standards: Legal and Social Considerations (Quality in Apheresis Center) |
|
12.00-12.30 |
Novel applications of CAR-T technologies |
Update on Indications: The 8th ASFA Guidelines |
|
12.30-13.30 |
Sponsored Lunch Symposium |
|
|
Scientific Session IV |
Scientific Session V |
|
|
Chairs: C. Webb, G. Öztürk |
Chairs: G. Özet, H. Vrielink |
|
|
Hall 1 |
Hall 2 |
|
|
13.30-14.00 |
Apheresis in the standard of care for sickle cell disease and new medical approaches |
Are we donating bone: impact of apheresis on bone density |
|
14.00-14.30 |
Gene Therapy Approaches to Sickle Cell Disease |
FGF23: the link between iron- and bone metabolism |
|
14.30-15.00 |
Mobilization for CD34+ collection in patients with Sickle Cell Disease |
Are we donating iron: impact of apheresis on ferritin levels |
|
15.00-15.30 |
Coffee Break (poster presenters / authors at their poster) |
|
|
Scientific Session VI |
Scientific Session VII |
|
|
Chairs: L. Pierelli, M. Karakükçü |
Chairs: H. Vrielink, A. Buser |
|
|
Hall 1 |
Hall 2 |
|
|
15.30-16.00 |
Use of CD34+ cells in ALD / MLD in pediatric patients |
COVID convalescent plasma: is there still a place for CCP? |
|
16.00-16.30 |
Poor CD34+ Mobilizers: How to Manage? |
Anti-D challenges in low and middle income countries |
| 16.30-17.00 | Plerixafor in the allo donor situation J. Cid |
Registry Session |
|
|
|
The first and other registries and why have one? |
|
History, update and future direction on the WAA registry. |
||
|
The Turkish registry |
||
|
17.00-17.15 |
Coffee Break |
|
|
Plenary Scientific Abstract Session (Oral Presentations) – HALL 1 |
||
|
Chairs: H. Vrielink, F. Altuntas, M.A. Erkurt, M. Lozano, |
||
|
17.15-17.30 |
O-01: Use of Therapeutic Plasma Exchange in the Management of Crimean-Congo Hemorrhagic Fever: A Single-Center Experience. |
|
|
17.30-17.45 |
O-02: Do Blood Groups Have An Effect On The Release Of Hematopoietic Stem Cells From The Bone Marrow Niche Into The Periphery? |
|
|
17.45-18.00 |
O-03: Is There Any predictive Laboratory Parameter To Predict The Success Of Hemoadsorption In Sepsis? |
|
|
18.00-18.15 |
O-04: Difference in CD34+ Collection Efficacy Between Non-Hodgkin Lymphoma and Multiple Myeloma |
|
|
18.15-18.30 |
O-05: Outcomes of Autologous Peripheral Stem Cell Transplantation in Hodgkin’s Lymphoma Patients: A Single Center Experience. |
|
|
18.30-19.30 |
ESFH general assembly (ESFH members only) |
|
16 September 2022 (Friday), Day 3 |
||
|
07.00-17.00 |
Registration |
|
|
Breakfast with the Experts (first come, first served) |
||
|
07.00-08.15 |
· Apheresis in LMICs (H. Vrielink) · ECP procedures (C. Webb) · Apheresis in pediatric patients (B.A. Aksoy) · TTP (G. Rock) · JACIE/FACT (N. Worel, J. Schwartz) · CAR-T, CAR-B and CAR-NKs (F. Altuntas) · Venous access (M-J. Mustieles) |
|
|
Scientific Session VIII |
Educational Session III |
|
|
Chairs: W. Szpirt, S.K. Beşışık |
Chairs: B. Turgut, N. Worel |
|
|
Hall 1 |
Hall 2 |
|
|
08.30-09.00 |
Therapeutic apheresis in ANCA Associated Vasculitis: Current Status of Pexivas. |
Indications for Photopheresis |
|
09.00-09.30 |
Pulmonary hemorrhage, pulmonary renal syndrome and therapeutic plasma exchange K. le Poole |
Vascular Access for Apheresis: State of the Art |
|
09.30-10.00 |
ECP in autoimmune disorders |
Current technology in ECP |
|
10.00-10.30 |
Coffee Break |
|
|
Scientific Session IX |
Scientific Abstract Session II |
|
|
Chairs: R. Sarode, G. Rock |
Chairs: R. Weinstein, J. Schwartz |
|
|
Hall 1 |
Hall 2 |
|
|
10.30-11.00 |
TTP in the Caplacizumab era |
10.30-10.45 – O-06: Adverse Reactions during TPE in Liver Disease Patients M. Bajpai |
|
11.00-11.30 |
Biomarkers of response and prognosis in TTP |
10.45-11.00 – O-07: Plasmapheresis Experience in COVID-19 M. A. Karaselek |
|
11.30-12.00 |
Is there a role for TPE in managing Vaccine-Induced Immune Thrombotic Thrombocytopenia? |
11.00-11.15 – O-08: Evaluation of TPE in Pediatric Patients B. Tutun |
|
11.15-11.30 – O-09: Treatment costs of IVIg versus TPE for GBS, MG and CIPD in inpatient and outpatient settings |
||
|
11.30-11.45 – O-10: TPE for Management of Maternal Hyperthyroidism Complicated with Fetal Goiter Due to Graves Disease with High T3, Low T4 Pattern |
||
|
11.45-12.00 – O-11: Evaluation of Indications, Complications, Outcomes and Hospital Mortality of TPE Applied Patients |
||
|
12.00-13.00 |
Lunch |
|
|
Scientific Session X |
Education Session IV |
|
|
Chairs: A. Buser, N. Yalman |
Chairs: D. Özatlı, R. Moog |
|
|
Hall 1 |
Hall 2 |
|
|
13.00-13.30 |
Use of adsorption techniques in ABO incompatible kidney transplant |
Apheresis in pregnancy |
|
13.30-14.00 |
Column Immunopheresis® therapy in solid tumors. |
Apheresis in patients on anticoagulation |
|
14.00-14.30 |
Apheresis in pediatric patients |
|
|
14.30-15.30 |
Coffee Break & Poster Session 2 |
|
|
Scientific Session XI |
Scientific Abstract Session III |
|
|
Chairs: |
Chairs: W. Szpirt, M. Lozano |
|
|
Hall 1 |
Hall 2 |
|
|
15.30-16.00 |
Blood Services Management in Turkey and the role of the Turkish Red Crescent |
15.30-15.45 – O-12: Collection of CD3+ Cells in Donors and Patients with Spectra Optia® K. le Poole |
|
16.00-16.30 |
Turkish Red Crescent and Plasma Fractionation |
15.45-16.00 – O-13: A Prospective Paired Study Comparing the MNC collection Using an in-line Against an off-line ECP Apheresis System |
|
16.30-17.00 |
NAT practices in Turkish Red Crescent |
16.00-16.15 – O-14: LW-02 Column Immunopheresis® Therapy Clinical Experience In Refractory Solid Tumors – Removal Of Soluble TNF Receptors (Stnf-Rs) To Promote Antitumor Activity Of Endogenous TNF-Α |
|
16.15-16.30 – O-15: TTP Successfully Treated with Rituximab but with no Presence of ADAMTS13 Antibody |
||
|
16.30-16.45 – O-16: Prevention of Hypertriglyceridemia-Induced Acute Pancreatitis in Pregnant State; Lipid Apheresis as a Bridge to Delivery |
||
|
17.00-17.30 |
Closing Ceremony – HALL 1 (F. Altuntaş, H. Vrielink, M. Lozano, L. Pierelli) Presentation of Awards Introduction of New Board of Directors |
|
|
19.00-22.00 |
Gala Dinner (Ticketed Event) |
|
17 September 2022 (Saturday), Day 4 |
||
|
09.00-10.00 |
WAA Board of Directors Post-Conference Meeting (by invitation only) Room: Turkuaz |
|
|
09.00-10.00 |
ESFH Board of Directors Post-Conference Meeting (by invitation only) Room: Elmas |
|
|
10.00-12.00 |
Joint Meeting: |
|
